United States · FDA National Drug Code directory
RECARBRIO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-3856_11f74255-d000-4759-a561-136a5f13f667
- Product NDC
- 0006-3856
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- imipenem anhydrous, cilastatin, and relebactam anhydrous
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200106
- Source listing expiry
- 20261231
Source-listed ingredients
- IMIPENEM ANHYDROUS — 500 mg/100mL
- CILASTATIN — 500 mg/100mL
- RELEBACTAM ANHYDROUS — 250 mg/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, SINGLE-DOSE in 1 CARTON (0006-3856-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0006-3856-01) · 0006-3856-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →